Session Details

C010 Dermatology Review: General

Sat, Mar 9, 9:00 AM - 12:00 PM
Room 32B
3 CME Available Course Ticketed
View Map

DESCRIPTION

Tuition fee and ticket required for admission

In this session topics of interest to dermatologists will be presented where there have been significant advances or updates. In particular, the evaluation and treatment of bullous diseases, Graft vs host disease, morphea, lupus, dermatomyositis, as is autoimmune blistering diseases, sarcoid, and atopic dermatitis. There are new treatments for atopic dermatitis that will be discussed, including new developments with JAK inhibitors and biologics.

LEARNING OBJECTIVES

1.

Discuss new developments in atopic dermatitis, autoimmune blistering diseases, sarcoidosis patient care.

2.

Discuss the diagnose and treatment options of graft versus host disease.

3.

Discuss evaluation and treatment options of autoimmune skin diseases.

SCHEDULE

5:00 PM

Review of bullous diseases

Mary M Tomayko, MD, PhD, FAAD

5:25 PM

Q&A

5:30 PM

Review of Graft vs Host Disease

Emily Baumrin, MSCE, MD, FAAD

5:55 PM

Q&A

6:00 PM

Update in Morphea/Scleroderma

Nicole Fett, MD, FAAD

6:25 PM

Q&A

6:30 PM

Update in Lupus and Dermatomyositis

Victoria P. Werth, MD, FAAD

6:55 PM

Q&A

7:00 PM

Sarcoidosis

Avrom Caplan, MD, FAAD

7:25 PM

Q&A

7:30 PM

New developments in atopic dermatitis

Eric Lawrence Simpson, MD, FAAD

7:55 PM

Q&A

SPEAKERS

Emily Baumrin, MSCE, MD, FAAD

Emily Baumrin, MSCE, MD, FAAD

Avrom Caplan, MD, FAAD

Avrom Caplan, MD, FAAD

Nicole Fett, MD, FAAD

Nicole Fett, MD, FAAD

Eric Lawrence Simpson, MD, FAAD

Eric Lawrence Simpson, MD, FAAD

Mary M Tomayko, MD, PhD, FAAD

Mary M Tomayko, MD, PhD, FAAD

Victoria P. Werth, MD, FAAD

Victoria P. Werth, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Emily Baumrin, MSCE, MD, FAAD

No financial relationships exist with ineligible companies.

Avrom Caplan, MD, FAAD

No financial relationships exist with ineligible companies.

Nicole Fett, MD, FAAD

Sanofi – Speaker/Faculty Education(Honoraria);

Eric Lawrence Simpson, MD, FAAD

AbbVie – Consultant(Fees), Investigator(Grants/Research Funding); Acrotech Biopharma Inc – Investigator(Grants/Research Funding); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant(Fees); Arcutis, Inc. – Investigator(Grants/Research Funding); Areteia Therapeutics – Consultant (1099 relationship)(Fees); ASLAN – Consultant(Fees); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Fees); Castle Biosciences – Investigator(Grants/Research Funding); CorEvitas – Consultant(Fees), Investigator(Grants/Research Funding); Corvus Pharmaceuticals – Consultant (1099 relationship)(Fees); Demira – Consultant(Fees); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees), Investigator(Grants/Research Funding); Evelo Biosciences, Inc. – Consultant(Fees); FIDE – Speaker/Faculty Education(Fees); Forte Biosciences – Consultant(Fees); Galderma Laboratories, LP – Consultant (1099 relationship)(Fees); Gilead Sciences, Inc – Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant(Fees); Impetus Healthcare – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Innovaderm Research Inc. – Consultant (1099 relationship)(Fees); Janssen Research & Development, LLC – Consultant(Fees); Johnson & Johnson Pharmaceutical Research & Development – Consultant(Fees); Kymab – Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Med Learning Group – Consultant(Fees); Merck – Advisory Board(Fees); National Jewish Health – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); NUMAB Therapeutics AG – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Physicians World LLC – Consultant(Fees); Prime Education – Speaker/Faculty Education(Honoraria); Recludix Pharma – Consultant (1099 relationship)(Fees); Regeneron – Consultant(Fees), Investigator(Grants/Research Funding); Roivant Sciences – Consultant(Fees); Sanofi – Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Fees), Investigator(Grants/Research Funding); SITRYX – Consultant (1099 relationship)(Fees); Target RWE – Investigator(Grants/Research Funding); Tioga Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Trevi Therapeutics – Consultant(Fees); Valeant Pharmaceuticals International – Consultant(Fees); Vanda Pharmaceuticals Inc. – Investigator(Grants/Research Funding); Veriskin – Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria); WebMD – Consultant(Fees);

Mary M Tomayko, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Victoria P. Werth, MD, FAAD

Alpine Immune Sciences – Consultant (1099 relationship)(Honoraria); Alumis – Consultant(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); arGEN-X – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); Biohaven – Consultant(Honoraria); BMS – Consultant(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); Corcept Therapeutics – Consultant(Honoraria); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kezar Life Sciences – Consultant(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Kyverna Therapeutics – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Mirobio – Consultant(Honoraria); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Octapharma – Consultant(Honoraria); Ono – Consultant(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); Scienomics – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Vertex Pharmaceuticals Incorporated – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria); Xencor – Consultant (1099 relationship)(Honoraria);